Acetylcholinesterase
(AChE) is one of the most important drug targets
for Alzheimer’s disease (AD) treatment. In this work, a machine
learning model was trained to rapidly and accurately screen large
chemical databases for the potential inhibitors of AChE. The obtained
results were then validated via in vitro enzyme assay. Moreover, atomistic
simulations including molecular docking and molecular dynamics simulations
were then used to understand molecular insights into the binding process
of ligands to AChE. In particular, two compounds including benzyl
trifluoromethyl ketone and trifluoromethylstyryl ketone were indicated
as highly potent inhibitors of AChE because they established IC
50
values of 0.51 and 0.33 μM, respectively. The obtained
IC
50
of two compounds is significantly lower than that
of galantamine (2.10 μM). The predicted log(BB) suggests that
the compounds may be able to traverse the blood–brain barrier.
A good agreement between computational and experimental studies was
observed, indicating that the hybrid approach can enhance AD therapy.